1 reports of this reaction
7.7% of all ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE reports
#11 most reported adverse reaction
POST HERPETIC NEURALGIA is the #11 most commonly reported adverse reaction for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE, manufactured by ARMY AND AIR FORCE EXCHANGE SERVICE. There are 1 FDA adverse event reports linking ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE to POST HERPETIC NEURALGIA. This represents approximately 7.7% of all 13 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE who experience post herpetic neuralgia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
POST HERPETIC NEURALGIA is moderately reported among ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE users, representing a notable but not dominant share of adverse events.
In addition to post herpetic neuralgia, the following adverse reactions have been reported for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE:
POST HERPETIC NEURALGIA has been reported as an adverse event in 1 FDA reports for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
POST HERPETIC NEURALGIA accounts for approximately 7.7% of all adverse event reports for ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE, making it a notable side effect.
If you experience post herpetic neuralgia while taking ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.